About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 709037, 6 pages
http://dx.doi.org/10.1155/2013/709037
Research Article

A Comparison between 18F-FDG PET/CT Imaging and Biological and Radiological Findings in Restaging of Hepatoblastoma Patients

1Positron Emission Tomography Centre, IRMET S.p.A., Euromedic Inc., 10136 Turin, Italy
2Co-ordinator of PET Pediatric AIMN InterGroup, 10136 Turin, Italy
3Associate researcher of Institute of Cognitive Sciences and Technologies, National Research Council, 00185 Rome, Italy
4Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, 6500 Bellinzona, Switzerland
5Pediatric Unit, Hospital Cirie' ASL To4, 10073 Cirie' (TO), Italy
6Department of Radiological Sciences, HSR Giglio, 90015 Cefalù (PA), Italy
7Paediatric Oncohematologic Unit, Department of Paediatric Oncology, Regina Margherita Children’s Hospital, 10126 Turin, Italy
8Department of Haematology, Oncology, Immunology and Infectious Diseases, Regina Margherita Children’s Hospital, 10126 Turin, Italy
9Nuclear Medicine Unit, La Maddalena Hospital, 90146 Palermo, Italy
10Nuclear Medicine Unit, Department of Biomedical Sciences and of Morphologic and Functional Images, University of Messina, 98125 Messina, Italy

Received 29 April 2013; Accepted 20 July 2013

Academic Editor: Sherif Heiba

Copyright © 2013 Angelina Cistaro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. E. Herzog, R. J. Andrassy, and F. Eftekhari, “Childhood cancers: hepatoblastoma,” Oncologist, vol. 5, no. 6, pp. 445–453, 2000. View at Scopus
  2. J. B. Litten and G. E. Tomlinson, “Liver tumors in children,” Oncologist, vol. 13, no. 7, pp. 812–820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. M. Chung, G. E. Lattin Jr., R. Cube et al., “From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation part 2. malignant tumors,” Radiographics, vol. 31, no. 2, pp. 483–507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. J. Gregory Jr. and J. L. Finlay, “α-fetoprotein and β-human chorionic gonadotropin. Their clinical significance as tumour markers,” Drugs, vol. 57, no. 4, pp. 463–467, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Zsíros, R. Maibach, E. Shafford et al., “Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study,” Journal of Clinical Oncology, vol. 28, no. 15, pp. 2584–2590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. F. Avila, A. L. Luis, F. Hernandez et al., “Liver transplantation for malignant tumours in children,” European Journal of Pediatric Surgery, vol. 16, no. 6, pp. 411–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hertl and A. B. Cosimi, “Liver transplantation for malignancy,” Oncologist, vol. 10, no. 4, pp. 269–281, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Parikh, A. Jojo, B. Shah, R. Bansal, P. Trivedi, and M. J. Shah, “Fine needle aspiration cytology of hepatoblastoma: a study of 20 cases,” Indian Journal of Pathology and Microbiology, vol. 48, no. 3, pp. 331–336, 2005. View at Scopus
  9. S. J. King, P. S. Babyn, M. L. Greenberg, M. J. Phillips, and R. M. Filler, “Value of CT in determining the resectability of hepatoblastoma before and after chemotherapy,” American Journal of Roentgenology, vol. 160, no. 4, pp. 793–798, 1993. View at Scopus
  10. D. Iacob, A. Serban, O. Fufezan et al., “Mixed hepatoblastoma in child. Case report,” Medical ultrasonography, vol. 12, no. 2, pp. 157–162, 2010. View at Scopus
  11. G. Perilongo, E. Shafford, and J. Plaschkes, “SIOPEL trials using preoperative chemotherapy in hepatoblastoma,” Lancet Oncology, vol. 1, no. 2, pp. 94–100, 2000. View at Scopus
  12. M. S. Figarola, S. A. McQuiston, F. Wilson, and R. Powell, “Recurrent hepatoblastoma with localization by PET-CT,” Pediatric Radiology, vol. 35, no. 12, pp. 1254–1258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Abbasoǧlu, F. Gün, F. Tansu Salman et al., “Hepatoblastoma in children,” Acta Chirurgica Belgica, vol. 104, no. 3, pp. 318–321, 2004. View at Scopus
  14. S. Sironi, C. Messa, A. Cistaro et al., “Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG positron emission tomography,” American Journal of Roentgenology, vol. 182, no. 5, pp. 1214–1216, 2004. View at Scopus
  15. K. K. Y. Wong, L. C. L. Lan, S. C. L. Lin, and P. K. H. Tam, “The use of positron emission tomography in detecting hepatoblastoma recurrence—a cautionary tale,” Journal of Pediatric Surgery, vol. 39, no. 12, pp. 1779–1781, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Philip, A. Shun, G. McCowage, and R. Howman-Giles, “Positron emission tomography in recurrent hepatoblastoma,” Pediatric Surgery International, vol. 21, no. 5, pp. 341–345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. J. Mody, J. A. Pohlen, S. Malde, P. J. Strouse, and B. L. Shulkin, “FDG PET for the study of primary hepatic malignancies in children,” Pediatric Blood and Cancer, vol. 47, no. 1, pp. 51–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Aronson, J. M. Schnater, C. R. Staalman et al., “Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study,” Journal of Clinical Oncology, vol. 23, no. 6, pp. 1245–1252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Pritchard, J. Brown, E. Shafford et al., “Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach—results of the first prospective study of the International Society of Pediatric Oncology,” Journal of Clinical Oncology, vol. 18, no. 22, pp. 3819–3828, 2000. View at Scopus
  20. P. O. Alderson, D. F. Adams, and B. J. McNeil, “Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison,” Radiology, vol. 149, no. 1, pp. 225–230, 1983. View at Scopus
  21. M. A. Amendola, C. E. Blane, B. E. Amendola, and G. M. Glazer, “CT findings in hepatoblastoma,” Journal of Computer Assisted Tomography, vol. 8, no. 6, pp. 1105–1109, 1984. View at Scopus
  22. A. Horie, Y. Kotoo, and T. Hayashi, “Ultrastructural comparison of hepatoblastoma and hepatocellular carcinoma,” Cancer, vol. 44, no. 6, pp. 2184–2193, 1979. View at Scopus
  23. K. A. Warfel and M. T. Hull, “Hepatoblastomas: an ultrastructural and immunohistochemical study,” Ultrastructural Pathology, vol. 16, no. 4, pp. 451–461, 1992. View at Scopus
  24. N. Shiojiri, “Enzymo- and immunocytochemical analyses of the differentiation of liver cells in the prenatal mouse,” Journal of Embryology and Experimental Morphology, vol. 62, pp. 139–152, 1981. View at Scopus
  25. C. D. Patel and R. Kumar, “Positron emission tomography and positron emission tomography-computerized tomography in pediatric patients,” Journal of Indian Association of Pediatric Surgeons, vol. 12, no. 3, pp. 120–124, 2007. View at Scopus
  26. W. T. Yang and P. J. Johnson, “Monitoring response to treatment in liver tumours,” Bailliere's Best Practice and Research in Clinical Gastroenterology, vol. 13, no. 4, pp. 637–654, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Bertagna, E. Orlando, G. Bosio et al., “Incremental diagnostic value of F-18 FDG PET/CT over MRI in a pediatric patient with suspected hepatoblastoma and histologic diagnosis of focal nodular hyperplasia,” Clinical nuclear medicine, vol. 36, no. 4, pp. 305–308, 2011. View at Scopus
  28. E. J. Groen, A. Roos, F. L. Muntinghe et al., “Extra-intestinal manifestations of familial adenomatous polyposis,” Annals of Surgical Oncology, vol. 15, no. 9, pp. 2439–2450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Perilongo and E. A. Shafford, “Liver tumours,” European Journal of Cancer, vol. 35, no. 6, pp. 953–959, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. B. McCarville and D. J. Roebuck, “Diagnosis and staging of hepatoblastoma: imaging aspects,” Pediatric Blood & Cancer, vol. 9, no. 5, pp. 793–799, 2012. View at Publisher · View at Google Scholar
  31. F. A. Falix, D. C. Aronson, W. H. Lamers, et al., “DLK1, a serum marker for hepatoblastoma in young infants,” Pediatric Blood & Cancer, vol. 59, pp. 743–745, 2012. View at Publisher · View at Google Scholar
  32. A. Shammas, R. Lim, and M. Charron, “Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions,” Radiographics, vol. 29, no. 5, pp. 1467–1486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. P. Finn, M. A. HaIl-Craggs, C. Dicks-Mireaux, et al., “Primary malignant liver tumors in childhood: assessment of resectability with high-field MR and comparison with CT,” Pediatric Radiology, vol. 21, pp. 34–38, 1990.
  34. G. J. R. Cook, E. A. Wegner, and I. Fogelman, “Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging,” Seminars in Nuclear Medicine, vol. 34, no. 2, pp. 122–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Huda and A. Vance, “Patient radiation doses from adult and pediatric CT,” American Journal of Roentgenology, vol. 188, no. 2, pp. 540–546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. F. H. Fahey, “Dosimetry of pediatric PET/CT,” Journal of Nuclear Medicine, vol. 50, no. 9, pp. 1483–1491, 2009. View at Publisher · View at Google Scholar · View at Scopus